Shanahan Karin

Shanahan Karin is listed in filings as EVP at Bristol-Myers Squibb Co. This profile follows SEC Form 4 activity through Apr 2, 2026, including 22 public disclosures. Recent filings connect the profile to Bristol-Myers Squibb Co (BMY). The current snapshot covers public activity from Mar 12, 2025 to Apr 2, 2026. Reported amounts are shown as $104.4K to $90.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.